The U.S. Patent and Trademark Office will offer a webinar entitled "Biopharma Patents in China: Litigation, Licensing, and Patent Linkage" on February 24, 2022 from 9:30 am to 11:00 am (ET). The webinar will feature presentations by senior U.S. Patent and Trademark Office IP attorneys and seasoned practitioners with extensive China IP experience. Topics to be covered include:
• Challenges and opportunities for U.S. companies as licensors and licensees of biopharmaceutical technologies in China
• An overview of recent changes to IP legislation and patent examination guidelines in China
• China's newly implemented patent linkage system
• Strategic considerations for licensing of biopharmaceutical patents in China
• Biopharmaceutical patent litigation in China
Those interested in registering for the webinar can do so here.
Comments